Management of Acute Infectious Wheeze in Children

Immediate Management of the Wheeze Episode

The American Academy of Pediatrics recommends administering albuterol (short-acting beta-agonist) as the cornerstone of acute treatment for the wheezing episode, regardless of whether this represents viral-induced wheeze or an asthma exacerbation 1, 4
The treatment should include oral prednisolone 1-2 mg/kg/day for 3-5 days if the child presents with tachypnea, chest retractions, or moderate-to-severe respiratory distress, as recommended by the American College of Allergy, Asthma, and Immunology 1, 2

The American Academy of Neurology recommends using ibuprofen at weight-appropriate dosing as the preferred first-line medication for the migraine symptoms in this child 3, 5
Ibuprofen serves dual purposes: it treats both the migraine headache and provides anti-inflammatory effects that may benefit the respiratory symptoms, according to the American Headache Society 3, 5

The American Thoracic Society recommends evaluating whether this child requires long-term controller therapy by assessing the Asthma Predictive Index, which includes major criteria such as parental history of asthma and physician-diagnosed atopic dermatitis 1, 6
The Asthma Predictive Index also includes minor criteria such as physician-diagnosed allergic rhinitis, wheezing apart from colds, and peripheral blood eosinophilia >4%, as stated by the American College of Allergy, Asthma, and Immunology 1, 6

The American Academy of Pediatrics recommends scheduling follow-up in 4-8 weeks to determine if this was an isolated viral episode or part of a pattern suggesting underlying asthma, and to document interval symptoms such as daytime wheeze, nighttime cough, activity limitation, and frequency of rescue bronchodilator use 1
If migraine attacks occur ≥2 times per month producing disability lasting ≥3 days, consider preventive migraine therapy with propranolol or amitriptyline under specialist supervision, as recommended by the American Academy of Neurology 3, 7

The American Academy of Pediatrics warns against using over-the-counter cough and cold medications in children under 2 years due to lack of efficacy and risk of serious toxicity including death 2
The American College of Allergy, Asthma, and Immunology advises against withholding corticosteroids based on older equivocal studies when the child presents with acute respiratory distress requiring medical attention, and against prescribing antibiotics for uncomplicated viral-induced wheeze 2, 4